Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study

Diabetes Care

Volumn 37, Issue 1, 2014, Pages 31-38

  Martin, Catherine L ^a   Albers, James W ^a   Pop Busui, Rodica ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; DIABETIC PERIPHERAL NEUROPATHY; DISEASE COURSE; DISEASE DURATION; EPIGASTRIC FULLNESS; ERECTILE DYSFUNCTION; GLYCEMIC CONTROL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTENSIVE CARE; LOWER URINARY TRACT SYMPTOM; PERIPHERAL NEUROPATHY; PREVALENCE; RETINOPATHY; RISK REDUCTION; TREATMENT RESPONSE; URINE INCONTINENCE; ADOLESCENT; ADULT; AGED; BLOOD; BLOOD PRESSURE; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NERVE CONDUCTION; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; YOUNG ADULT;

GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; RISK FACTORS; YOUNG ADULT;

EID: 84892425163     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2114     Document Type: Article

References (30)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
2. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995;38:869-880
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial(DCCT). Diabetologia 1998;41:416-423
4. Epidemiology of Diabetes Interventions and Complications (EDIC). Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999;22:99-111
5. Martin CL, Waberski BH, Pop-Busui R, et al.;DCCT/EDIC Research Group. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type1 diabetes: Results from the DCCT/EDIC study. Diabetes Care 2010;33:2635-2641
6. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical twostep quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-1289
7. Herman WH, Pop-Busui R, Braffett BH,et al.; DCCT/EDIC Research Group. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in type1 diabetes: Results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med 2012;29:937-944
8. Martin CL, Albers J, Herman WH, et al.;DCCT/EDIC Research Group. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 2006;29:340-344
9. Pop-Busui R, Low PA, Waberski BH, et al.;DCCT/EDIC Research Group. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type1 diabetes mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation 2009;119:2886-2893
10. Van Den Eeden SK, Sarma AV, Rutledge BN,et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Research Group. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms inmen with type 1 diabetes:Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care 2009;32:664-670
11. Yang CC, Porter MP, Penson DF.Comparison of the International Index of Erectile Function erectile domain scores and nocturnal penile tumescence and rigidity measurements: Does one predict the other BJU Int 2006;98:105- 109;discussion 109
12. Sarma AV, Kanaya A, Nyberg LM, et al.;Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Risk factors for urinary incontinence among women with type 1 diabetes: Findings from the epidemiology of diabetes interventions and complications study. Urology 2009;73:1203-1209
13. Sarma AV, Kanaya AM, Nyberg LM, et al.;Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Urinary incontinence among women with type 1diabetesdhow common is it J Urol 2009;181:1224-1230; discussion 1230
14. Pop-Busui R, Cleary PA, Braffett BH, et al.;DCCT/EDIC Research Group. Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). J Am Coll Cardiol 2013;61:447-454
15. Albers JW, HermanWH, Pop-Busui R, et al.;Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) study. Diabetes Care 2010;33:1090 1096 care.diabetesjournals.org Martin, Albers, and Pop-Busui 37
16. Pop-Busui R, Herman WH, Feldman EL, et al.; DCCT/EDIC Research Group. DCCT and EDIC studies in type 1 diabetes: Lessons for diabetic neuropathy regarding metabolic memory and natural history.Curr Diab Rep 2010;10:276-282
17. Albers JW, Herman WH, Pop-Busui R,Martin CL, Cleary P, Waberski B; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Intervention and Complications (EDIC) Research Group.Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: Possible predictors of incident neuropathy Diabetes Care 2007;30:2613-2618
18. Wessells H, Penson DF, Cleary P, et al.;Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. J Urol 2011;185:1828-1834
19. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005;366:1719-1724
20. Tesfaye S, Boulton AJ, Dyck PJ, et al.; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285-2293
21. Maser RE,Mitchell BD, Vinik AI, Freeman R.The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: A meta-analysis.Diabetes Care 2003;26:1895-1901
22. Pop-Busui R, Evans GW, Gerstein HC, et al.;Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010;33:1578-1584
23. Pop-Busui R. What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res 2012;5:463-478
24. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002;287:2563-2569
25. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-2167
26. Klein R, Klein BE, Moss SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996;124:90-96
27. Maser RE, Steenkiste AR, Dorman JS, et al.;Report from Pittsburgh Epidemiology of Diabetes Complications Study.Epidemiological correlates of diabetic neuropathy. Diabetes 1989;38:1456-1461
28. Tesfaye S, Chaturvedi N, Eaton SE, et al.;EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341-350
29. Spallone V, Ziegler D, Freeman R, et al.;Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: Clinical impact,assessment, diagnosis, and management.Diabetes Metab Res Rev 2011;27:639-653
30. Sacre JW, Franjic B, Jellis CL, Jenkins C,Coombes JS, Marwick TH. Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes. JACC Cardiovasc Imaging 2010;3:1207-1215 Kidney Diseases Kidney Diseases